PIEZO1 and central nervous system cancer: Piezo1 expression correlates with glioma grade, with higher expression in more aggressive, high-grade tumours, suggesting its role in tumour progression and severity.66, 67, 68 Subsequently, Piezo1 has been proposed as a prognostic indicator and a potential therapeutic target in patients with GBM.66, 67, 68